Umphumela
Igama lomkhiqizo: I-CAGRILITIDIDIDE
I-oda elincane: ama-vials / ibhokisi / ibhokisi elingu-10,
Inkokhelo: I-T / T, ikhadi lesikweletu, ukudluliselwa kwebhange, i-Alibaba, i-Alipay, eWechat, ehlakaniphile
Ukupakisha okujwayelekile: 5mg / vial, 10mg / vial, 15mg / vial, 20mg / vial, 30mg / vial
I-Pharmacological Mechanism:
I-Cagritintide yinde - I-Amylin analogue esebenzisa imiphumela yayo ngalezi zindlela ezilandelayo:
1.Redulating Appetie: Ukubambezeleka kokukhipha isisulu, ukwanda kwengqondo, kanye nokunciphisa ukudla.
I-2.Central Weight Loss: Izenzo kwi-hypothalalic feeding Center ukucindezela amasignali endlala.
Umphumela we-3.Syneergistic (njengamalungiselelo ahlanganisiwe): Uma uhlanganiswe ne-glp-1 receptor agonists (njengeSemaglutide), ingalawula i-metabolism embaxambili futhi ithuthukise ukunciphisa umzimba kanye nemiphumela ye-hypoglycemic.
Izinzuzo Zomkhiqizo
Umphumela we-Hypoglycemifmic onamandla: Ukubonakaliswa kwemitholampilo kukhombisa ukuncishiswa okukhulu ku-HBA1C (kuze kufike ku-2.0% -2.5%).
Umphumela Wesisindo Esivelele: Ukulahleka kwesisindo okujwayelekile kungafinyelela ku-15% - 22% (iqembu eliphakeme).
Izinzuzo ezingaba khona zenhliziyo: Ucwaningo lokuqala luphakamisa ukuthi izici zobungozi bezinhliziyo zingathuthukiswa.
Amashadi ashisayo: phezulu